Preclinical research: Make mouse studies work (original) (raw)

• Comment
• Published: 26 March 2014

Nature volume 507, pages 423–425 (2014)Cite this article

• 17k Accesses
• 629 Citations
• 290 Altmetric
• Metrics details

Subjects

More investment to characterize animal models can boost the ability of preclinical work to predict drug effects in humans, says Steve Perrin.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

• Selective vulnerability of motor neuron types and functional groups to degeneration in amyotrophic lateral sclerosis: review of the neurobiological mechanisms and functional correlates

  • Saak V. Ovsepian
  • , Valerie B. O’Leary
  • & Salvador Martinez
    Brain Structure and Function Open Access 24 November 2023

• Neocortex neurogenesis and maturation in the African greater cane rat

  • Oluwaseun Mustapha
  • , Thomas Grochow
  • … Simone A. Fietz
    Neural Development Open Access 13 October 2023

• Breast cancer brain metastasis: from etiology to state-of-the-art modeling

  • Mohammad Kamalabadi Farahani
  • , Maliheh Gharibshahian
  • … Ahmad Vaez
    Journal of Biological Engineering Open Access 29 June 2023

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

References

1. Scott, S. et al. Amyotroph. Lateral Scler. 9, 4–15 (2008).
   Article CAS Google Scholar
2. Begley, C. G. & Ellis, L. M. Nature 483, 531–533 (2012).
   Article ADS CAS Google Scholar
3. Ling, S.-C., Polymenidou, M. & Cleveland, D. W. Neuron 79, 416–438 (2013).
   Article CAS Google Scholar
4. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. & Baloh, R. H. Proc. Natl Acad. Sci. USA 106, 18809–18814 (2009).
   Article ADS CAS Google Scholar
5. Hatzipetros, T. et al. Brain Res. http://dx.doi.org/10.1016/j.brainres.2013.10.013 (2013).
6. Ludolph, A. C. et al. Amyotroph. Lateral Scler. 11, 38–45 (2010).
   Article Google Scholar
7. Stallings, N. R., Puttaparthi, K., Luther, C. M., Burns, D. K. & Elliott, J. L. Neurobiol. Dis. 40, 404–414 (2010).
   Article CAS Google Scholar
8. Fornai, F. et al. Proc. Natl Acad. Sci. USA 105, 2052–2057 (2008).
   Article ADS CAS Google Scholar
9. UKMND-LiCALS Study Group Lancet Neurol. 12, 339–345 (2013).
10. Verstraete, E. et al. J. Neurol. Neurosurg. Psychiatr. 83, 557–564 (2012).
    Article Google Scholar
11. Aggarwal, S. P. et al. Lancet Neurol. 9, 481–488 (2010).
    Article CAS Google Scholar
12. Gill, A., Kidd, J., Vieira, F., Thompson, K. & Perrin, S. PLoS ONE 4, e6489 (2009).
    Article ADS Google Scholar
13. Pizzasegola, C. et al. Amyotroph. Lateral Scler. 10, 221–228 (2009).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

1. Steve Perrin is chief scientific officer at the ALS Therapy Development Institute in Cambridge, Massachusetts, USA.,
   Steve Perrin

Corresponding author

Correspondence toSteve Perrin.

Supplementary information

Related links

Rights and permissions

About this article

Cite this article

Perrin, S. Preclinical research: Make mouse studies work.Nature 507, 423–425 (2014). https://doi.org/10.1038/507423a

Download citation

• Published: 26 March 2014
• Issue date: 27 March 2014
• DOI: https://doi.org/10.1038/507423a

This article is cited by